SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001213900-24-070416
Filing Date
2024-08-19
Accepted
2024-08-19 08:00:45
Documents
4

Document Format Files

Seq Description Document Type Size
1 REVISED PRELIMINARY PROXY STATEMENT ea0211628-prer14a_cerothera.htm PRER14A 356594
2 GRAPHIC image_001.jpg GRAPHIC 3350
3 GRAPHIC image_002.jpg GRAPHIC 1822215
4 GRAPHIC image_003.jpg GRAPHIC 1588824
  Complete submission text file 0001213900-24-070416.txt   5059614
Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-40877 | Film No.: 241218280
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)